Education and Experience
- Yale University School of Medicine (New Haven CT)/ (1985)
- Beth Israel Deaconess Medical Center (Boston MA)/ OB/GYN (1989)
- National Cancer Institute - NIH (Bethesda MD)/ GYN Oncology (1999)
- Roswell Park Cancer Institute (Buffalo NY)/ GYN Oncology (1995)
- Uniformed Services University of the Health Sciences (Bethesda MD)/ Molecular Biology (1993)
- National Cancer Institute - NIH (Bethesda MD)/ Research Fellow (1992)
- Gynecologic Oncology, American Board of Obstetrics and Gynecology (2011)
- Obstetrics & Gynecology, American Board of Obstetrics and Gynecology (2011)
Gynecology and Obstetrics - Gynecologic Oncology
Responsible for developing and managing phase II trials in the chemoprevention of gynecologic cancers, with a combined budget of $6.2 million
Successfully broadened NCI portfolio for gynecologic malignancies
Gynecologic Oncologist, with background in molecular & cellular oncology
B.A., Chemistry, Bryn Mawr College, Bryn Mawr, PA
M.D., Yale University, New Haven, CT
Ph.D., Molecular and Cellular Oncology, George Washington University, Washington, DC
Assistant Professor, Johns Hopkins University, Baltimore, MD
Clinical Fellow, Roswell Park Cancer Institute, Buffalo, NY
Clinical Fellow, Harvard School of Medicine, Boston, MA
Residency/Internship training in Obstetrics and Gynecology, Beth Israel Hospital, Boston, MA
Gynecologic Oncology Fellowship training, Roswell Park Cancer Institute, Buffalo, NY
Research Fellowship training, Medicine & Radiation Oncology Branches, NCI, Bethesda, MD
Board Certified in Gynecologic Oncology and Obstetrics and Gynecology
Gynecologic Cancer Foundation/National Cancer Institute Research Fellowship,
Inaugural Fellow and Grant Recipient, 1995-1997
National Institutes of Health Clinical Research Loan Repayment Program, 1995-1997
Thomas J. Watson Memorial Scholarship, National Merit/Achievement, 1977-1981
Hannah E. Longshore Scholarship, Yale University School of Medicine, 1982
Belle and Herman Hammerman Scholarship, March of Dimes, 1982
Roswell Park Cancer Institute, Best Clinical Research Report, 1995
- Gynecology and Obstetrics
2008: Promoted to Captain (grade O-6) United States Public Health Service
1999-present: Program Director, Breast and Gynecologic Cancer Research Group, Division of Cancer Prevention, National Cancer Institute
1998-present: Faculty, Gynecologic Oncology, Johns Hopkins Hospital, Bethesda, MD
2002-present: Clinical Consultant, Gynecology Consult Service, NIH Clinical Center
First Gynecologic Cancer Foundation/National Cancer Institute Research Fellow, 1995-1998
Second gynecologic oncologist to hold permanent tenure equivalent position at NCI, 1998
Published numerous manuscripts in gynecologic oncology including ovarian cancer, cervical cancer, endometrial cancer, human papillomavirus (HPV), radiation-induced fibrosis
Lectured extensively on risk factors, early detection, and prevention of gynecologic malignancies; genetics of gynecologic malignancies; and on HPV vaccines
Cornelison TL, Reed E. Dose intensity analysis of high dose carboplatin in refractory ovarian carcinoma relative to age and clinical response. Cancer 1993; 71(2 Suppl):650-655.
Lee KB, Parker RJ, Bohr V, Cornelison TL, Reed E. Cisplatin sensitivity/resistance in UV-repair deficient chinese hamster ovary cells of complementation groups 1 and 3. Carcinogenesis 1993; 14:2177-2180.
Reed E, Janik J, Bookman MA, Rothenberg M, Smith J, Young RC, Ozols RF, VanderMolen L, Kohn E, Jacob JL, Cornelison TL. High dose carboplatin and recombinant granulocyte-macrophage colony-stimulating factor in advanced stage recurrent ovarian cancer. J Clin Oncol 1993; 11:2118-2126.
Cornelison TL, Baker TR, Piver MS, Driscoll DL. Cisplatin, adriamycin, etoposide, megestrol acetate (PAV-M) versus melphalan, 5-fluorouracil, medroxyprogesterone acetate (MFP) in the treatment of endometrial carcinoma. Gynecol Oncol 1995; 59:243-248.
Cornelison TL, Goldberg JM, Piver MS. Taxol and platinum chemotherapy in the treatment of pancreatic and jejunal carcinoma. J Surg Oncol 1995; 59:204-208.
Cornelison TL, Natarajan N, Piver MS, Mettlin CL. Tubal ligation and the risk of ovarian carcinoma. Cancer Detect Prev 1997; 21:1-6.
Cornelison TL, Trimble EL, Kosary CL. SEER data, corpus uteri cancer: treatment trends versus survival for FIGO stage II, 1988-1994. Gynecol Oncol 1999; 74:350-355.
Del Carmen MG, Montz FJ, Bristow RE, Bovicelli A, Cornelison TL, Trimble EL. Ethnic differences in patterns of care of stage IA1 and stage IA2 cervical cancer: a SEER data base study. Gynecol Oncol 1999; 75:113-117.
Montz FJ, Farber FL, Bristow RE, Cornelison TL. Impact of increasing Papanicolaou test sensitivity and compliance: a modeled cost and outcomes analysis. Obstet Gynecol 2001; 97:781-788.
Cornelison TL, Montz FJ, Bristow RE, Chou B, Bovicelli A, Zeger SL. Decreased incidence of cervical cancer in medicare-eligible California women. Obstet Gynecol 2002; 100:79-86.
Trimble EL, Schoenfeldt M, Cornelison TL, Wright J, Kolker A, Christian M. Clinical trials referral resource. Clinical trials in ovarian cancer; part 1. Oncology (Huntington) 2002; 16:1498-1499, 1504, 1506-1507.
Trimble EL, Schoenfeldt M, Cornelison TL, Wright J, Kolker A, Christian M. Clinical trials referral resource, Clinical trials in ovarian cancer; part 2. Oncology (Huntington) 2002; 16:1660-1662, 1665-1667.
Trimble EL, Schoenfeldt M, Streicher H, Guis D, Cornelison TL. Clinical trials referral resource. Clinical trials in cervical cancer. Oncology (Huntington) 2003; 17:84-89.
Trimble EL, Schoenfeldt M, Cornelison TL. Clinical trials referral resource. Clinical trials in endometrial cancer. Oncology (Huntington) 2003; 17:238-240, 244, 249.
Spitzer M, Wilkinson EJ, Ferris D, Waxman AG, Hatch KD, Werner C, Bibbo M, Colgan TJ, Cornelison T, Partridge EE. Management of women with cervical cytologic results interpreted as low-grade squamous intraepithelial lesion: the foundation of the ASCCP guidelines. J Low Genit Tract Dis 2003; 7:241-249.
Okunieff P, Augustine E, Hicks JE, Cornelison TL, Altemus RM, Naydich BG, Ding I, Huser AK, Abraham EH, Smith JJ, Coleman N, Gerber LH. Pentoxifylline in the treatment of radiation-induced fibrosis. J Clin Oncol 2004; 22:2207-2213.
Okunieff P, Cornelison TL, Mester M, Liu W, Ding I, Chen Y, Zhang H, Williams JP, Finkelstein J. Mechanism and modification of gastrointestinal soft tissue response to radiation: role of growth factors. Int J Radiat Oncol Biol Phys 2005; 62:273-278.
The American College of Obstetricians and Gynecologists, Fellow, 1999 present
Commissioned Officers Association of the United States Public Health Service, 1996 1998, 2006 2008
American Association for Cancer Research, 1990 1992, 1996 1998
Medical Society of the District of Columbia, 1990 1992
American Medical Womens Association, 1987 1989
American Medical Association, 1984 1985